Go Pro

Acacia Research (ACTG) Financials

Acacia Research logo
$4.54 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$4.54 +0.00 (+0.11%)
As of 07/2/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Acacia Research

Annual Income Statements for Acacia Research

This table shows Acacia Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-160 -54 22 -105 -35 172 149 -125 67 -36 22
Consolidated Net Income / (Loss)
-157 -55 -72 -105 -17 109 150 -111 69 -35 24
Net Income / (Loss) Continuing Operations
-157 -55 -72 -105 -17 109 150 -111 69 -35 24
Total Pre-Tax Income
-153 -37 25 -104 -19 108 175 -127 67 -38 31
Total Operating Income
-153 -37 -0.05 -25 -23 -20 15 -40 21 -33 6.41
Total Gross Profit
107 130 26 52 -7.04 4.96 12 35 72 30 84
Total Revenue
125 153 65 132 11 30 48 72 125 122 285
Operating Revenue
125 153 65 132 11 30 88 59 125 122 285
Total Cost of Revenue
18 23 40 80 18 25 36 37 53 93 201
Operating Cost of Revenue
18 23 40 80 18 25 36 37 53 93 201
Total Operating Expenses
259 167 26 77 16 24 37 62 51 63 78
Selling, General & Admin Expense
42 33 1.20 21 16 24 36 53 44 55 65
Marketing Expense
- - - - - 0.00 1.54 8.62 6.91 7.22 13
Total Other Income / (Expense), net
-0.11 0.80 -69 -79 4.47 128 201 -100 46 -5.22 25
Interest Expense
0.00 0.00 - - 0.00 -166 7.92 6.43 2.06 6.46 8.99
Interest & Investment Income
-0.06 0.00 52 -0.78 -12 9.03 3.59 - - 18 11
Other Income / (Expense), net
-0.06 0.80 -27 -78 16 -47 205 -94 49 -16 23
Income Tax Expense
4.80 18 2.96 1.18 -1.82 -1.16 24 -16 -1.50 -3.45 6.84
Net Income / (Loss) Attributable to Noncontrolling Interest
2.56 -0.73 -0.50 0.18 -17 0.00 1.17 14 1.87 1.36 2.79
Basic Earnings per Share
($3.25) ($1.08) $0.44 ($2.10) ($0.35) $1.78 $2.43 ($3.13) $0.73 ($0.36) $0.23
Weighted Average Basic Shares Outstanding
49.51M 50.08M 50.50M 49.97M 49.76M 48.84M 48.80M 42.46M 75.30M 99.21M 96.29M
Diluted Earnings per Share
($3.25) ($1.08) $0.44 ($2.10) ($0.40) $1.48 $1.91 ($3.13) $0.58 ($0.36) $0.22
Weighted Average Diluted Shares Outstanding
49.51M 50.08M 50.69M 49.97M 50.90M 57.44M 46.47M 58.57M 99.90M 96.09M 96.48M
Weighted Average Basic & Diluted Shares Outstanding
49.51M 50.08M 50.64M 49.65M 50.39M 49.28M 46.47M 58.57M 99.90M 96.09M 96.48M

Quarterly Income Statements for Acacia Research

This table shows Acacia Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
1.64 69 -0.19 -8.45 -14 -13 24 -3.29 -2.73 3.42 -16
Consolidated Net Income / (Loss)
2.76 76 -0.19 -8.83 -12 -14 24 -1.44 -2.39 4.77 -18
Net Income / (Loss) Continuing Operations
2.76 76 -0.19 -8.83 -12 -14 24 -1.44 -2.39 4.77 -18
Total Pre-Tax Income
2.57 73 -1.30 -16 -6.16 -15 30 -0.89 -3.36 5.95 -20
Total Operating Income
-13 56 -2.09 -4.76 -10 -16 38 -12 -6.43 -13 -8.36
Total Gross Profit
1.76 77 12 6.76 2.35 8.59 59 6.54 13 6.40 12
Total Revenue
12 101 24 26 23 49 124 51 59 50 54
Operating Revenue
10 92 24 26 23 49 124 51 59 50 54
Total Cost of Revenue
9.85 24 12 19 21 40 65 45 47 44 42
Operating Cost of Revenue
9.85 24 12 19 21 40 65 45 47 44 42
Total Operating Expenses
13 12 14 12 13 24 21 19 19 19 20
Selling, General & Admin Expense
12 11 12 10 11 22 17 16 16 16 17
Marketing Expense
1.61 1.52 1.56 1.39 1.39 2.88 3.31 3.38 3.08 3.18 3.12
Total Other Income / (Expense), net
14 9.00 0.79 -11 4.11 1.01 -8.70 11 3.06 19 -12
Interest Expense
0.13 0.13 0.33 1.81 1.95 6.44 2.45 2.33 2.23 1.98 1.89
Interest & Investment Income
- - - 4.99 4.54 - 2.51 2.94 3.00 - 2.82
Other Income / (Expense), net
14 7.78 1.12 -14 1.52 36 -8.76 11 2.29 16 -13
Income Tax Expense
-0.20 -2.15 -1.11 -7.06 5.50 -0.78 6.08 0.55 -0.97 1.18 -2.56
Net Income / (Loss) Attributable to Noncontrolling Interest
1.13 10 -0.00 -0.38 2.34 -0.78 -0.76 1.86 0.34 1.36 -1.86
Basic Earnings per Share
($0.02) $0.99 $0.00 ($0.08) ($0.14) ($0.14) $0.25 ($0.03) ($0.03) $0.04 ($0.16)
Weighted Average Basic Shares Outstanding
94.33M 75.30M 99.75M 100.08M 99.85M 99.21M 96.02M 96.24M 96.45M 96.29M 96.49M
Diluted Earnings per Share
($0.03) $1.04 $0.00 ($0.08) ($0.14) ($0.14) $0.25 ($0.03) ($0.03) $0.03 ($0.16)
Weighted Average Diluted Shares Outstanding
99.89M 99.90M 100.02M 100.38M 97.37M 96.09M 96.17M 96.44M 96.46M 96.48M 96.59M
Weighted Average Basic & Diluted Shares Outstanding
99.89M 99.90M 100.02M 100.38M 97.37M 96.09M 96.17M 96.44M 96.46M 96.48M 96.59M

Annual Cash Flow Statements for Acacia Research

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.76 -7.68 -2.45 -7.80 -36 108 109 -22 52 -66 33
Net Cash From Operating Activities
-9.95 34 13 21 -2.31 -20 13 -37 -23 50 75
Net Cash From Continuing Operating Activities
39 19 54 21 -2.31 -20 13 -37 -23 50 75
Net Income / (Loss) Continuing Operations
-157 -55 22 -105 -17 109 150 -111 69 -35 24
Consolidated Net Income / (Loss)
-157 -55 22 - -17 109 150 -111 69 -35 24
Depreciation Expense
53 34 22 27 3.23 4.80 11 14 15 34 43
Non-Cash Adjustments To Reconcile Net Income
106 50 -51 126 -19 -133 -173 90 -30 3.97 3.75
Changes in Operating Assets and Liabilities, net
-11 4.86 20 -28 31 -7.86 25 -30 -76 47 3.67
Net Cash From Investing Activities
39 -41 -16 -24 -68 19 36 184 16 -213 -21
Net Cash From Continuing Investing Activities
39 -41 -16 -24 -68 19 36 184 16 -213 -21
Purchase of Property, Plant & Equipment
-0.01 -0.00 -0.00 -0.03 -0.18 -0.20 -0.09 -0.73 -0.19 -149 -17
Acquisitions
-20 -1.23 - 0.00 -4.42 -294 -54 -5.00 -15 -102 1.23
Purchase of Investments
-23 -63 -480 -103 -147 -46 -67 -112 -13 -20 -25
Sale and/or Maturity of Investments
82 43 468 86 84 360 161 302 35 58 34
Other Investing Activities, net
0.00 -20 -4.00 -7.00 0.00 -0.41 -4.02 - 9.97 0.00 -15
Net Cash From Financing Activities
-29 -1.11 0.70 -4.61 34 109 60 -166 59 98 -23
Net Cash From Continuing Financing Activities
-29 -1.11 0.70 -4.61 34 109 60 -166 59 98 -23
Repayment of Debt
- - - - 0.00 -0.50 -50 -120 -68 56 -22
Repurchase of Common Equity
0.00 -0.08 -0.05 -4.86 0.00 -4.00 -4.01 -51 0.00 -20 0.00
Issuance of Debt
- - - - 0.00 110 115 - 0.00 47 0.00
Issuance of Common Equity
0.00 0.00 - 0.00 0.00 4.60 - - 0.00 15 0.00
Other Financing Activities, net
0.94 0.33 0.75 0.26 0.08 0.05 0.20 7.65 128 -0.87 -0.65
Effect of Exchange Rate Changes
- - - - - - 0.00 -2.57 0.00 -0.93 1.34
Cash Interest Paid
- - - - - 1.26 7.34 7.23 2.51 5.06 8.30
Cash Income Taxes Paid
- - - - - -3.48 0.03 0.38 0.83 1.05 2.30

Quarterly Cash Flow Statements for Acacia Research

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-10 -4.64 99 -52 -27 -85 -1.92 45 -15 4.94 0.79
Net Cash From Operating Activities
1.16 -4.54 55 16 -0.57 -20 2.43 50 9.55 13 3.40
Net Cash From Continuing Operating Activities
1.16 -4.54 55 16 -0.94 -20 2.43 50 9.55 13 3.40
Net Income / (Loss) Continuing Operations
2.76 76 -0.19 -8.83 -12 -14 24 -1.44 -2.39 4.77 -18
Consolidated Net Income / (Loss)
2.76 76 -0.19 -8.83 -12 -14 24 -1.44 -2.39 4.77 -18
Depreciation Expense
3.36 4.58 4.57 7.41 9.76 12 11 11 11 10 8.49
Non-Cash Adjustments To Reconcile Net Income
-12 -12 -8.47 10 -1.16 3.23 31 -30 2.03 0.93 13
Changes in Operating Assets and Liabilities, net
7.00 -73 59 6.92 2.11 -21 -62 70 -0.83 -3.01 -0.27
Net Cash From Investing Activities
-0.60 7.56 42 -152 -7.23 -96 1.04 -1.49 -14 -6.31 -0.98
Net Cash From Continuing Investing Activities
-0.60 7.56 42 -152 -7.23 -96 1.04 -1.49 -14 -6.31 -0.98
Purchase of Property, Plant & Equipment
-0.02 -0.04 -0.27 -143 -2.23 -3.29 -2.09 -2.21 -6.06 -6.33 -9.19
Acquisitions
- -15 0.00 - -5.00 -88 1.23 - - - -1.75
Purchase of Investments
-2.84 -4.39 -16 - - -4.93 -4.83 -7.72 -4.83 -7.34 0.00
Sale of Property, Plant & Equipment
- - - - - - 0.00 - - - 1.58
Sale and/or Maturity of Investments
2.25 17 58 - - - 6.73 8.44 - 19 8.38
Net Cash From Financing Activities
-11 -7.72 1.83 84 -19 31 -6.07 -4.27 -10 -1.99 -1.90
Net Cash From Continuing Financing Activities
-11 -7.72 1.83 84 -19 31 -6.07 -4.27 -10 -1.99 -1.90
Repayment of Debt
- -7.70 0.00 - - -18 -5.60 -4.10 -14 2.01 -1.58
Other Financing Activities, net
49 -0.02 -0.67 -0.17 - -0.02 -0.47 -0.17 - -0.01 -0.32
Effect of Exchange Rate Changes
-0.04 0.06 -0.03 - 0.17 - 0.69 0.40 0.16 0.09 0.27

Annual Balance Sheets for Acacia Research

This table presents Acacia Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
348 296 309 224 218 511 799 483 634 756 771
Total Current Assets
184 188 140 201 173 458 731 428 555 420 450
Cash & Equivalents
135 128 137 129 57 166 309 288 340 274 307
Short-Term Investments
0.00 19 0.00 37 111 286 399 98 100 60 54
Note & Lease Receivable
- - - - - - - - - 0.00 15
Accounts Receivable
34 27 0.15 33 0.51 0.51 9.52 8.23 81 27 26
Inventories, net
- - - - - 0.00 8.93 14 11 27 27
Prepaid Expenses
4.22 3.25 2.94 3.13 2.91 5.83 4.76 19 23 32 21
Plant, Property, & Equipment, net
0.27 0.00 0.00 0.00 0.00 0.27 4.18 3.54 2.36 24 21
Total Noncurrent Assets
164 108 169 22 45 53 64 51 77 312 300
Goodwill
- - - - - 0.00 7.47 7.54 8.99 29 26
Intangible Assets
- - - 6.59 7.81 17 49 37 34 55 48
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - 0.00 2.92 20 15
Other Noncurrent Operating Assets
164 89 167 7.70 2.08 1.46 7.31 7.21 31 207 211
Total Liabilities & Shareholders' Equity
348 296 309 224 218 511 799 483 634 756 771
Total Liabilities
34 29 13 33 35 212 354 194 44 204 187
Total Current Liabilities
33 28 9.56 31 12 125 200 87 28 50 49
Accounts Payable
17 14 7.96 8.00 9.03 4.73 12 20 12 33 33
Current Deferred Revenue
- - - - - 0.00 1.11 1.23 0.98 1.32 0.95
Current Employee Benefit Liabilities
- - - 0.35 0.51 2.27 3.70 4.74 4.21 6.28 6.73
Other Current Liabilities
15 14 1.60 23 2.18 2.16 2.46 0.70 11 6.99 8.35
Total Noncurrent Liabilities
0.52 0.37 3.55 1.67 23 87 153 106 16 154 138
Long-Term Debt
- - - - - - - 0.00 11 112 92
Asset Retirement Reserve & Litigation Obligation
- - - - - - - - 0.29 31 33
Noncurrent Deferred & Payable Income Tax Liabilities
0.21 0.00 - - - 0.00 19 0.74 0.00 2.61 2.15
Other Noncurrent Operating Liabilities
0.31 0.37 3.55 1.67 23 87 134 105 5.48 8.87 11
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
314 267 296 191 175 288 430 269 590 553 584
Total Preferred & Common Equity
310 266 294 189 173 277 419 258 568 515 543
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
310 266 294 189 173 277 419 258 568 515 543
Common Stock
633 643 649 651 652 651 648 663 906 910 915
Retained Earnings
-288 -342 -320 -423 -440 -331 -182 -307 -240 -276 -254
Treasury Stock
-35 -35 -35 -39 -39 -43 -47 -98 -98 -119 -119
Accumulated Other Comprehensive Income / (Loss)
-0.22 -0.08 -0.09 - - - - - 0.00 -1.18 0.67
Noncontrolling Interest
3.94 1.85 1.36 1.85 1.83 11 11 11 21 38 41

Quarterly Balance Sheets for Acacia Research

This table presents Acacia Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
485 557 535 529 632 754 708 802 776 769 756
Total Current Assets
427 505 486 484 553 494 458 465 444 441 431
Cash & Equivalents
242 364 355 345 439 387 360 272 317 302 308
Short-Term Investments
159 97 90 101 60 55 51 55 58 64 51
Note & Lease Receivable
- - - - - - - - - 3.39 8.14
Accounts Receivable
7.04 8.67 6.27 5.90 15 19 11 96 23 27 29
Inventories, net
14 15 14 12 9.88 12 12 26 26 26 23
Prepaid Expenses
5.17 20 21 20 29 21 24 16 20 18 12
Plant, Property, & Equipment, net
3.70 3.28 2.95 2.65 2.09 2.32 2.37 23 23 22 20
Total Noncurrent Assets
54 48 46 42 76 257 248 314 309 306 305
Goodwill
7.47 7.54 7.54 7.54 8.99 8.99 8.99 26 26 26 26
Intangible Assets
40 34 31 28 30 36 31 68 62 55 45
Noncurrent Deferred & Refundable Income Taxes
- - - 0.32 6.57 14 8.42 17 17 17 18
Other Noncurrent Operating Assets
7.21 6.97 7.84 6.63 31 198 199 203 204 208 215
Total Liabilities & Shareholders' Equity
485 557 535 529 632 754 708 802 776 769 756
Total Liabilities
184 179 176 26 42 157 129 224 198 192 189
Total Current Liabilities
85 90 78 21 26 44 28 75 50 51 50
Accounts Payable
14 21 10 14 8.69 18 14 37 34 34 35
Current Deferred Revenue
1.40 1.21 1.02 1.15 1.07 0.91 1.27 1.40 0.73 0.85 1.26
Current Employee Benefit Liabilities
5.07 5.49 5.51 5.20 4.62 3.98 4.97 6.88 6.39 7.99 5.96
Other Current Liabilities
3.26 1.06 0.58 1.30 3.01 6.41 7.76 28 7.27 8.55 8.24
Total Noncurrent Liabilities
99 89 98 4.12 16 113 101 149 148 141 138
Long-Term Debt
- - - - 13 82 70 106 102 94 91
Asset Retirement Reserve & Litigation Obligation
- - - - - 28 28 31 32 32 33
Noncurrent Deferred & Payable Income Tax Liabilities
2.71 0.50 0.13 0.00 - - - 2.70 2.70 2.61 2.18
Other Noncurrent Operating Liabilities
95 88 98 3.62 2.89 2.93 3.02 8.77 11 12 13
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
282 356 335 504 590 597 579 577 577 577 567
Total Preferred & Common Equity
258 345 324 493 568 561 540 540 539 538 529
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
258 345 324 493 568 561 540 540 539 538 529
Common Stock
644 740 739 905 906 907 908 911 912 913 916
Retained Earnings
-288 -297 -316 -314 -240 -248 -262 -251 -255 -258 -270
Treasury Stock
-98 -98 -98 -98 -98 -98 -106 -119 -119 -119 -119
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - -0.52 0.35 0.23 0.78
Noncontrolling Interest
25 11 11 11 21 36 38 37 39 39 39

Annual Metrics And Ratios for Acacia Research

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
50,736,407.00 50,463,380.00 50,604,782.00 49,639,319.00 50,343,305.00 49,279,453.00 49,591,852.00 - - - 96,460,378.00
DEI Adjusted Shares Outstanding
50,736,407.00 50,463,380.00 50,604,782.00 49,639,319.00 50,343,305.00 49,279,453.00 49,591,852.00 - - - 96,460,378.00
DEI Earnings Per Adjusted Shares Outstanding
-3.15 -1.07 0.44 -2.12 -0.69 3.49 3.01 - - - 0.22
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.46% 22.12% -57.17% 101.07% -91.45% 164.82% 59.96% 51.82% 72.97% -2.23% 133.20%
EBITDA Growth
-1,042.27% 97.73% -122.92% -1,406.10% 95.07% -1,377.07% 517.47% -152.22% 170.05% -97.78% 558.41%
EBIT Growth
-143.31% 76.02% 25.51% -277.26% 93.24% -862.50% 427.50% -161.00% 151.93% -145.63% 158.83%
NOPAT Growth
-145.55% 75.49% 99.82% -36,951.81% 5.15% -20.34% 163.48% -324.11% 176.26% -207.69% 121.73%
Net Income Growth
-136.23% 65.20% -31.44% -45.57% 83.66% 737.70% 37.66% -173.78% 162.13% -150.34% 170.52%
EPS Growth
-137.23% 66.77% 140.74% -577.27% 80.95% 470.00% 29.05% -263.87% 118.53% -162.07% 161.11%
Operating Cash Flow Growth
-337.79% 442.36% -61.93% 61.01% -111.06% -750.09% 167.92% -380.17% 39.72% 322.71% 50.12%
Free Cash Flow Firm Growth
161.64% 146.35% -228.80% 283.25% -82.39% 46.18% -28.33% -384.48% -187.79% -6.18% 111.64%
Invested Capital Growth
-43.18% -46.30% 73.65% -88.79% -215.43% -251.95% -13.98% 44.18% 452.55% 107.73% -5.34%
Revenue Q/Q Growth
5.45% -9.23% -22.06% 53.34% -81.18% 33.72% 44.44% -4.14% 183.60% -32.95% 0.45%
EBITDA Q/Q Growth
-1,984.50% 97.75% -103.36% 67.57% 55.52% -258.89% 211.27% -128.18% 147.31% -93.66% 6.07%
EBIT Q/Q Growth
-176.63% 74.10% -121.54% 59.59% 68.79% -328.99% 199.11% -132.42% 136.28% -1,111.74% 23.49%
NOPAT Q/Q Growth
-179.09% 73.57% 99.83% -65.25% -300.72% 13.59% 155.59% -628.25% 161.70% -154.15% 152.92%
Net Income Q/Q Growth
-179.87% 66.02% -159.47% 64.76% 41.20% 453.54% 317.87% -198.92% 374.09% -163.29% 331.27%
EPS Q/Q Growth
-164.23% 66.46% -81.67% 48.02% 32.20% 1,038.46% 565.85% -621.67% 203.57% -143.90% 340.00%
Operating Cash Flow Q/Q Growth
-31.76% 206.44% -71.67% 244.40% -118.42% -580.06% 138.69% -514.57% 46.03% -23.87% 79.88%
Free Cash Flow Firm Q/Q Growth
172.23% -23.40% 60.24% -33.37% -48.19% 125.91% -93.40% 70.36% -40.49% -42.31% 134.77%
Invested Capital Q/Q Growth
-37.93% -13.50% -35.74% -65.21% -507.69% -169.12% 68.71% -16.93% 178.15% 40.05% 3.26%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
85.23% 85.11% 39.06% 39.52% -62.62% 16.65% 24.23% 48.31% 57.77% 24.24% 29.62%
EBITDA Margin
-79.49% -1.48% -7.69% -57.60% -33.19% -185.14% 483.19% -166.22% 67.32% 1.53% 25.38%
Operating Margin
-122.06% -24.50% -0.08% -18.77% -208.23% -65.54% 30.53% -55.43% 16.74% -26.92% 2.25%
EBIT Margin
-122.11% -23.98% -41.70% -78.24% -61.89% -224.93% 460.53% -185.03% 55.55% -25.92% 10.18%
Profit (Net Income) Margin
-125.95% -35.89% -110.13% -79.73% -152.31% 366.77% 315.63% -153.39% 55.10% -28.37% 8.58%
Tax Burden Percent
103.14% 149.68% -292.33% 101.14% 90.38% 101.07% 86.09% 87.25% 102.23% 90.96% 78.15%
Interest Burden Percent
100.00% 100.00% -90.35% 100.76% 272.31% -161.33% 79.61% 95.02% 97.03% 120.31% 107.82%
Effective Tax Rate
0.00% 0.00% 11.99% 0.00% 0.00% -1.07% 13.91% 0.00% -2.23% 0.00% 21.85%
Return on Invested Capital (ROIC)
-46.03% -20.26% -0.04% -19.81% 0.00% 0.00% 0.00% 0.00% 37.29% -9.35% 1.55%
ROIC Less NNEP Spread (ROIC-NNEP)
-16.15% -2.54% 45.53% 36.24% 0.00% 0.00% 0.00% 0.00% 24.85% -5.76% -6.42%
Return on Net Nonoperating Assets (RNNOA)
6.81% 1.41% -25.54% -23.25% 0.00% 0.00% 0.00% 0.00% -21.61% 3.27% 2.76%
Return on Equity (ROE)
-39.21% -18.84% -25.58% -43.07% -9.15% 45.30% 40.40% -30.21% 15.69% -6.08% 4.31%
Cash Return on Invested Capital (CROIC)
9.04% 39.99% -53.86% 139.87% 0.00% 0.00% 0.00% 0.00% -115.01% -79.37% 7.03%
Operating Return on Assets (OROA)
-34.53% -11.37% -9.02% -38.63% -3.15% -18.37% 33.49% -20.88% 12.45% -4.56% 3.80%
Return on Assets (ROA)
-35.62% -17.02% -23.82% -39.36% -7.75% 29.95% 22.95% -17.31% 12.35% -4.99% 3.20%
Return on Common Equity (ROCE)
-38.75% -18.66% -25.44% -42.78% -8.87% 42.30% 37.80% -27.87% 14.75% -5.76% 4.01%
Return on Equity Simple (ROE_SIMPLE)
-50.76% -20.63% -24.47% -55.36% -9.89% 39.39% 35.85% -42.95% 12.13% -6.74% 0.00%
Net Operating Profit after Tax (NOPAT)
-107 -26 -0.05 -17 -16 -20 13 -28 21 -23 5.01
NOPAT Margin
-85.44% -17.15% -0.07% -13.14% -145.76% -66.24% 26.29% -38.80% 17.11% -18.84% 1.76%
Net Nonoperating Expense Percent (NNEP)
-29.88% -17.71% -45.57% -56.05% -0.39% 44.93% 30.72% -19.24% 12.44% -3.59% 7.96%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 3.57% -3.46% 0.74%
Cost of Revenue to Revenue
14.77% 14.89% 60.94% 60.48% 162.62% 83.35% 75.77% 51.69% 42.23% 75.76% 70.38%
SG&A Expenses to Revenue
33.84% 21.89% 1.83% 16.22% 145.62% 82.18% 74.87% 72.84% 35.51% 45.26% 22.83%
R&D to Revenue
2.71% 2.02% 0.00% 0.00% 0.00% 0.00% 0.42% 0.87% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
207.30% 109.61% 39.15% 58.29% 145.62% 82.18% 78.52% 85.62% 41.04% 51.16% 27.37%
Earnings before Interest and Taxes (EBIT)
-153 -37 -27 -103 -6.96 -67 219 -134 69 -32 29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-99 -2.26 -5.03 -76 -3.73 -55 230 -120 84 1.87 72
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.70 1.24 0.70 0.78 0.77 0.70 0.61 0.71 0.69 0.82 0.66
Price to Tangible Book Value (P/TBV)
0.70 1.24 0.70 0.81 0.81 0.75 0.70 0.86 0.74 0.98 0.77
Price to Revenue (P/Rev)
1.74 2.15 3.13 1.12 11.91 6.52 5.34 2.53 3.13 3.45 1.26
Price to Earnings (P/E)
0.00 0.00 9.24 0.00 0.00 1.13 1.71 0.00 5.84 0.00 16.64
Dividend Yield
11.66% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 10.82% 0.00% 0.00% 88.45% 58.65% 0.00% 17.13% 0.00% 6.01%
Enterprise Value to Invested Capital (EV/IC)
0.45 1.69 0.43 0.00 0.00 0.00 0.00 0.00 0.00 0.72 0.42
Enterprise Value to Revenue (EV/Rev)
0.61 1.00 1.03 0.00 0.00 0.00 0.00 0.00 0.00 1.97 0.46
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 128.94 1.83
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.56
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 26.43
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 4.48 5.21 0.00 0.00 0.00 0.00 0.00 0.00 4.80 1.76
Enterprise Value to Free Cash Flow (EV/FCFF)
3.61 2.96 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.81
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.39 0.41 0.21 0.02 0.21 0.16
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.21 0.16
Financial Leverage
-0.42 -0.56 -0.56 -0.64 -1.01 -1.19 -1.21 -1.17 -0.87 -0.57 -0.43
Leverage Ratio
1.10 1.11 1.07 1.09 1.18 1.51 1.76 1.75 1.27 1.22 1.34
Compound Leverage Factor
1.10 1.11 -0.97 1.10 3.22 -2.44 1.40 1.66 1.23 1.46 1.45
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 27.88% 28.93% 17.29% 1.75% 17.10% 13.62%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 27.88% 28.93% 17.29% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.75% 17.10% 13.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.26% 0.69% 0.46% 0.97% 5.42% 5.29% 4.12% 8.86% 3.56% 5.67% 6.00%
Common Equity to Total Capital
98.74% 99.31% 99.54% 99.03% 94.58% 66.83% 66.95% 73.86% 94.69% 77.23% 80.38%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -2.10 0.79 -0.50 0.13 61.09 1.27
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 6.72 -2.29 2.71 -5.10 -117.78 -3.72
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 61.09 1.27
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -5.86 14.47 -2.15 0.49 -4.95 18.38
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 18.79 -42.06 11.61 -20.06 9.54 -53.70
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.49 -4.95 18.38
Altman Z-Score
2.14 6.03 8.36 0.06 0.30 0.05 1.88 -0.24 6.37 1.35 1.82
Noncontrolling Interest Sharing Ratio
1.17% 1.00% 0.57% 0.66% 3.14% 6.61% 6.42% 7.73% 5.95% 5.18% 6.90%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.53 6.69 14.62 6.49 14.79 3.67 3.65 4.91 20.06 8.89 9.18
Quick Ratio
5.08 6.16 14.31 6.39 14.41 3.62 3.58 4.52 18.83 7.64 8.21
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
21 52 -67 122 21 31 23 -64 -184 -196 23
Operating Cash Flow to CapEx
-124,362.50% 851,525.00% 648,300.00% 61,402.94% -1,261.20% -9,859.30% 14,643.96% -5,100.55% -11,907.94% 33.71% 450.71%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 2.84 -9.95 -89.32 -30.39 2.53
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 1.68 -5.80 -10.91 7.78 8.37
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 1.67 -5.92 -11.00 -15.30 6.51
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.28 0.47 0.22 0.49 0.05 0.08 0.07 0.11 0.22 0.18 0.37
Accounts Receivable Turnover
4.66 5.07 4.86 7.96 0.67 58.57 9.51 8.15 2.82 2.28 10.75
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.23 4.20 4.83 7.43
Fixed Asset Turnover
323.93 0.00 0.00 0.00 0.00 0.00 21.40 18.74 42.46 9.33 12.63
Accounts Payable Turnover
1.15 1.44 3.58 9.97 2.15 3.61 4.40 2.35 3.33 4.18 6.11
Days Sales Outstanding (DSO)
78.33 72.01 75.07 45.85 541.93 6.23 38.40 44.78 129.52 160.35 33.96
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 113.01 86.86 75.64 49.13
Days Payable Outstanding (DPO)
318.37 253.96 101.84 36.61 169.92 101.13 82.88 155.03 109.72 87.28 59.70
Cash Conversion Cycle (CCC)
-240.04 -181.95 -26.77 9.24 372.02 -94.90 -44.48 2.76 106.66 148.71 23.39
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
168 90 157 18 -20 -71 -81 -45 160 333 315
Invested Capital Turnover
0.54 1.18 0.53 1.51 -8.29 -0.65 -0.62 -1.14 2.18 0.50 0.88
Increase / (Decrease) in Invested Capital
-128 -78 67 -139 -38 -51 -9.99 36 206 173 -18
Enterprise Value (EV)
76 153 68 -24 -60 -155 -246 -111 -16 241 132
Market Capitalization
218 328 205 148 134 194 254 183 392 423 361
Book Value per Share
$6.11 $5.26 $5.82 $3.82 $3.44 $5.63 $8.46 $6.08 $5.69 $5.29 $5.63
Tangible Book Value per Share
$6.11 $5.26 $5.82 $3.68 $3.28 $5.28 $7.32 $5.04 $5.26 $4.42 $4.87
Total Capital
314 267 296 191 183 415 626 350 600 667 676
Total Debt
0.00 0.00 0.00 0.00 0.00 116 181 60 11 114 92
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11 114 92
Net Debt
-146 -177 -139 -174 -203 -371 -527 -326 -429 -220 -269
Capital Expenditures (CapEx)
0.01 0.00 0.00 0.03 0.18 0.20 0.09 0.73 0.19 149 17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.70 1.80 -6.47 4.97 -6.79 -2.82 4.27 15 87 39 40
Debt-free Net Working Capital (DFNWC)
151 160 130 170 162 449 712 401 527 373 401
Net Working Capital (NWC)
151 160 130 170 162 333 530 341 527 373 401
Net Nonoperating Expense (NNE)
51 29 72 88 0.74 -129 -138 83 -48 12 -19
Net Nonoperating Obligations (NNO)
-146 -177 -139 -174 -203 -371 -527 -335 -429 -220 -269
Total Depreciation and Amortization (D&A)
53 34 22 27 3.23 12 11 14 15 34 43
Debt-free, Cash-free Net Working Capital to Revenue
3.76% 1.18% -9.89% 3.78% -60.39% -9.45% 8.96% 20.85% 69.52% 32.00% 14.03%
Debt-free Net Working Capital to Revenue
120.49% 104.98% 198.98% 129.60% 1,436.51% 1,506.00% 1,494.03% 554.75% 421.16% 304.88% 140.61%
Net Working Capital to Revenue
120.49% 104.98% 198.98% 129.60% 1,436.51% 1,117.63% 1,113.57% 471.17% 421.16% 304.88% 140.61%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($3.25) ($1.08) $0.00 ($2.10) ($0.35) $0.00 $2.43 ($3.13) $0.73 ($0.36) $0.23
Adjusted Weighted Average Basic Shares Outstanding
50.46M 50.47M 0.00 49.97M 49.76M 0.00 48.80M 42.46M 75.30M 99.21M 96.29M
Adjusted Diluted Earnings per Share
($3.25) ($1.08) $0.00 ($2.10) ($0.40) $0.00 $1.91 ($3.13) $0.58 ($0.36) $0.22
Adjusted Weighted Average Diluted Shares Outstanding
50.46M 50.47M 0.00 49.97M 50.90M 0.00 46.47M 58.57M 99.90M 96.09M 96.48M
Adjusted Basic & Diluted Earnings per Share
($3.25) ($1.08) $0.00 ($2.10) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
49.51M 50.08M 0.00 49.65M 50.39M 0.00 46.47M 58.57M 99.90M 96.09M 96.48M
Normalized Net Operating Profit after Tax (NOPAT)
-33 3.45 1.93 2.46 -16 -14 13 -28 15 -23 5.01
Normalized NOPAT Margin
-26.73% 2.26% 2.95% 1.87% -145.76% -45.88% 26.29% -38.80% 11.71% -18.84% 1.76%
Pre Tax Income Margin
-122.11% -23.98% 37.67% -78.83% -168.53% 362.88% 366.62% -175.80% 53.90% -31.19% 10.98%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 27.69 -20.81 33.68 -4.92 3.23
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 1.58 -4.36 10.37 -3.58 0.56
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 27.68 -20.92 33.59 -28.01 1.37
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 1.57 -4.48 10.28 -26.67 -1.30
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-18.76% -2.48% 0.00% 0.00% 0.00% 1.27% 0.97% -2.52% 2.03% 0.00% 0.00%
Augmented Payout Ratio
-18.76% -2.63% -0.06% -4.64% 0.00% 4.93% 3.63% -48.48% 2.03% -58.47% 0.00%

Quarterly Metrics And Ratios for Acacia Research

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - 96,086,040.00 96,171,702.00 96,444,993.00 96,460,378.00 96,475,469.00
DEI Adjusted Shares Outstanding
- - - - - - 96,086,040.00 96,171,702.00 96,444,993.00 96,460,378.00 96,475,469.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - 0.25 -0.03 -0.03 0.04 -0.16
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-79.82% 410.47% 64.29% 1,372.18% 100.79% -51.51% 411.60% 98.30% 155.02% 2.63% -56.41%
EBITDA Growth
156.00% 135.22% -245.64% -37.28% -20.54% -52.65% 1,016.80% 185.30% 556.21% 249.65% -131.39%
EBIT Growth
110.18% 132.30% -312.52% -65.71% -626.50% -67.82% 3,140.12% 92.15% 52.79% 112.69% -171.38%
NOPAT Growth
-27.60% 665.36% 80.21% 62.02% 49.23% -119.22% 2,183.51% -160.30% 37.44% 5.21% -119.22%
Net Income Growth
-90.27% 506.37% -102.00% 52.98% -522.05% -118.57% 12,548.68% 83.72% 79.46% 134.04% -174.81%
EPS Growth
-250.00% 1,140.00% 100.00% 77.78% -366.67% -113.46% 0.00% 62.50% 78.57% 121.43% -164.00%
Operating Cash Flow Growth
-70.67% 80.86% 1,360.96% 209.09% -149.22% -345.91% -95.58% 210.57% 1,709.95% 164.90% 40.33%
Free Cash Flow Firm Growth
52.40% -220.90% -549.44% -421.46% -69.25% -24.03% -66.29% 70.38% 61.57% 103.96% 123.96%
Invested Capital Growth
248.21% 452.55% 457.02% 1,019.60% 312.59% 107.73% 244.41% 29.59% 28.39% -5.34% -16.60%
Revenue Q/Q Growth
671.59% 767.61% -77.68% 6.24% -9.78% 109.54% 154.73% -58.82% 16.02% -15.68% 8.20%
EBITDA Q/Q Growth
173.34% 1,406.57% -142.71% 66.84% 142.45% 797.83% 559.92% -76.69% -33.57% 97.75% -196.48%
EBIT Q/Q Growth
112.20% 5,345.90% -154.49% 47.31% 61.23% 432.81% 243.65% -104.67% -176.09% 163.15% -908.20%
NOPAT Q/Q Growth
-61.49% 506.53% -102.44% -127.98% -115.89% -53.90% 375.05% -128.48% 48.11% -133.19% 44.23%
Net Income Q/Q Growth
114.71% 2,633.53% -100.25% -4,571.43% -32.03% -20.30% 267.78% -106.11% -66.60% 299.37% -468.76%
EPS Q/Q Growth
91.67% 3,566.67% -100.00% 0.00% -75.00% 0.00% 278.57% -112.00% 0.00% 200.00% -633.33%
Operating Cash Flow Q/Q Growth
107.85% -491.72% 1,306.84% -70.61% -103.54% -3,448.51% 111.97% 1,966.80% -80.95% 37.74% -74.12%
Free Cash Flow Firm Q/Q Growth
-116.95% -33.86% 7.49% -97.20% 29.58% 1.91% -22.08% 64.88% 8.62% 110.11% 638.81%
Invested Capital Q/Q Growth
323.67% 178.15% -34.97% 127.29% 0.35% 40.05% 7.82% -14.48% -0.58% 3.26% -5.01%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
15.18% 76.09% 49.16% 26.16% 10.09% 17.59% 47.37% 12.77% 21.20% 12.76% 22.23%
EBITDA Margin
39.05% 67.80% -105.23% -32.84% 15.45% 66.21% 32.28% 19.42% 11.12% 26.07% -23.24%
Operating Margin
-113.30% 55.54% -8.58% -18.41% -44.07% -32.37% 30.79% -24.17% -10.81% -26.10% -15.41%
EBIT Margin
10.08% 63.26% -124.01% -61.50% -26.43% 41.97% 23.75% -2.92% -6.95% 5.21% -38.89%
Profit (Net Income) Margin
23.79% 74.96% -0.78% -34.17% -50.01% -28.71% 18.91% -2.80% -4.03% 9.52% -32.45%
Tax Burden Percent
107.68% 102.92% 14.56% 55.56% 189.24% 94.76% 79.46% 161.46% 71.21% 80.16% 87.28%
Interest Burden Percent
219.23% 115.13% 4.30% 100.00% 100.00% -72.19% 100.20% 59.45% 81.35% 228.12% 95.60%
Effective Tax Rate
-7.68% -2.92% 0.00% 0.00% 0.00% 0.00% 20.54% 0.00% 0.00% 19.84% 0.00%
Return on Invested Capital (ROIC)
-574.45% 124.62% -22.88% -20.85% -38.12% -11.24% 23.50% -15.42% -7.92% -18.42% -7.05%
ROIC Less NNEP Spread (ROIC-NNEP)
-578.76% 119.93% -23.17% -19.37% -36.98% -10.33% 25.46% -17.72% -8.60% -24.67% -2.22%
Return on Net Nonoperating Assets (RNNOA)
565.28% -104.26% 21.37% 15.09% 26.89% 5.87% -15.36% 9.51% 4.56% 10.61% 0.94%
Return on Equity (ROE)
-9.17% 20.35% -1.51% -5.76% -11.23% -5.37% 8.14% -5.91% -3.36% -7.82% -6.11%
Cash Return on Invested Capital (CROIC)
-227.69% -115.01% -98.43% -92.98% -93.13% -79.37% -107.74% -25.75% -24.13% 7.03% 9.54%
Operating Return on Assets (OROA)
0.88% 14.18% -29.82% -16.30% -7.80% 7.39% 7.37% -0.95% -2.67% 1.94% -10.74%
Return on Assets (ROA)
2.07% 16.80% -0.19% -9.06% -14.75% -5.05% 5.87% -0.91% -1.55% 3.56% -8.96%
Return on Common Equity (ROCE)
-8.55% 19.14% -1.43% -5.34% -10.71% -5.09% 7.73% -5.53% -3.13% -7.28% -5.70%
Return on Equity Simple (ROE_SIMPLE)
-5.11% 0.00% 10.43% 12.35% 10.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-14 58 -1.46 -3.33 -7.19 -11 30 -8.67 -4.50 -10 -5.85
NOPAT Margin
-122.00% 57.17% -6.01% -12.89% -30.85% -22.66% 24.46% -16.92% -7.57% -20.93% -10.79%
Net Nonoperating Expense Percent (NNEP)
4.31% 4.69% 0.29% -1.48% -1.14% -0.91% -1.96% 2.29% 0.69% 6.25% -4.83%
Return On Investment Capital (ROIC_SIMPLE)
- 9.59% - - - -1.66% 4.44% -1.27% -0.67% -1.55% -0.89%
Cost of Revenue to Revenue
84.82% 23.91% 50.84% 73.84% 89.91% 82.41% 52.63% 87.23% 78.80% 87.24% 77.77%
SG&A Expenses to Revenue
99.97% 11.28% 50.79% 38.51% 47.72% 44.91% 13.92% 30.34% 26.83% 32.52% 31.88%
R&D to Revenue
1.48% -0.59% 0.55% 0.69% 0.46% -0.86% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
115.34% 12.20% 57.74% 44.57% 54.15% 49.95% 16.58% 36.94% 32.01% 38.87% 37.63%
Earnings before Interest and Taxes (EBIT)
1.17 64 -30 -16 -6.16 21 30 -1.50 -4.13 2.61 -21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.53 68 -26 -8.49 3.60 32 40 9.95 6.61 13 -13
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.74 0.69 0.94 0.89 0.87 0.82 0.57 0.64 0.58 0.66 0.88
Price to Tangible Book Value (P/TBV)
0.80 0.74 1.01 0.97 0.93 0.98 0.69 0.76 0.69 0.77 1.01
Price to Revenue (P/Rev)
8.27 3.13 3.73 2.94 2.56 3.45 1.38 1.39 1.10 1.26 2.16
Price to Earnings (P/E)
6.41 5.84 10.38 8.13 10.17 0.00 0.00 0.00 64.83 16.64 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
15.59% 17.13% 9.63% 12.30% 9.83% 0.00% 0.00% 0.00% 1.54% 6.01% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.66 0.75 0.70 0.72 0.35 0.37 0.27 0.42 0.78
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.48 1.04 0.91 1.97 0.57 0.45 0.29 0.46 1.09
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 2.09 5.84 5.61 128.94 6.07 1.80 1.19 1.83 11.97
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 4.08 16.94 52.72 0.00 0.00 5.96 3.44 4.56 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 2.22 4.18 3.88 0.00 24.13 1,512.58 40.89 26.43 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 1.86 2.62 2.51 4.80 0.00 3.55 1.94 1.76 3.08
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.81 7.48
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.02 0.02 0.14 0.12 0.21 0.19 0.18 0.16 0.16 0.16
Long-Term Debt to Equity
0.00 0.02 0.02 0.14 0.12 0.21 0.18 0.18 0.16 0.16 0.16
Financial Leverage
-0.98 -0.87 -0.92 -0.78 -0.73 -0.57 -0.60 -0.54 -0.53 -0.43 -0.42
Leverage Ratio
1.26 1.27 1.23 1.35 1.14 1.22 1.23 1.30 1.28 1.34 1.36
Compound Leverage Factor
2.76 1.46 0.05 1.35 1.14 -0.88 1.23 0.77 1.04 3.07 1.30
Debt to Total Capital
0.00% 1.75% 2.16% 12.08% 10.79% 17.10% 15.81% 15.31% 14.01% 13.62% 13.76%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.35% 0.35% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 1.75% 2.16% 12.08% 10.79% 17.10% 15.46% 14.96% 14.01% 13.62% 13.76%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.19% 3.56% 3.54% 5.31% 5.92% 5.67% 5.40% 5.70% 5.85% 6.00% 5.89%
Common Equity to Total Capital
97.81% 94.69% 94.30% 82.61% 83.29% 77.23% 78.79% 78.99% 80.14% 80.38% 80.35%
Debt to EBITDA
0.00 0.13 0.40 2.70 2.38 61.09 5.22 1.67 1.38 1.27 4.61
Net Debt to EBITDA
0.00 -5.10 -14.85 -11.85 -11.58 -117.78 -10.51 -4.33 -3.98 -3.72 -13.66
Long-Term Debt to EBITDA
0.00 0.13 0.40 2.70 2.38 61.09 5.10 1.63 1.38 1.27 4.61
Debt to NOPAT
0.00 0.49 0.42 1.94 1.64 -4.95 20.74 1,401.82 47.48 18.38 -3.21
Net Debt to NOPAT
0.00 -20.06 -15.75 -8.49 -8.01 9.54 -41.79 -3,633.44 -137.20 -53.70 9.51
Long-Term Debt to NOPAT
0.00 0.49 0.42 1.94 1.64 -4.95 20.28 1,369.59 47.48 18.38 -3.21
Altman Z-Score
8.87 6.34 8.12 2.33 2.61 1.58 1.36 1.51 1.47 1.70 1.77
Noncontrolling Interest Sharing Ratio
6.75% 5.95% 5.57% 7.35% 4.57% 5.18% 5.00% 6.38% 6.72% 6.90% 6.62%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
22.60 20.06 21.40 11.17 16.39 8.89 6.16 8.80 8.63 9.18 8.56
Quick Ratio
21.08 18.83 19.88 10.42 15.10 7.64 5.60 7.90 7.76 8.21 7.85
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-111 -148 -135 -266 -187 -184 -224 -79 -72 7.27 54
Operating Cash Flow to CapEx
7,733.33% -12,281.08% 20,310.74% 11.28% -25.56% -615.87% 116.03% 2,264.80% 157.57% 207.68% 44.70%
Free Cash Flow to Firm to Interest Expense
-851.03 -1,113.50 0.00 0.00 0.00 -28.53 -91.49 -33.81 -32.27 3.68 28.49
Operating Cash Flow to Interest Expense
8.92 -34.17 0.00 0.00 0.00 -3.15 0.99 21.52 4.28 6.64 1.80
Operating Cash Flow Less CapEx to Interest Expense
8.81 -34.44 0.00 0.00 0.00 -3.66 0.14 20.57 1.56 3.45 -2.23
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.09 0.22 0.24 0.27 0.30 0.18 0.31 0.32 0.38 0.37 0.28
Accounts Receivable Turnover
6.82 2.82 11.89 13.64 21.94 2.28 4.00 11.76 14.99 10.75 3.46
Inventory Turnover
2.25 4.20 4.49 4.97 6.22 4.83 8.07 9.02 10.19 7.43 7.14
Fixed Asset Turnover
13.90 42.46 53.26 64.85 72.78 9.33 17.48 19.77 23.13 12.63 9.87
Accounts Payable Turnover
2.09 3.33 3.71 4.56 5.52 4.18 6.45 6.59 8.29 6.11 4.97
Days Sales Outstanding (DSO)
53.52 129.52 30.71 26.77 16.64 160.35 91.16 31.04 24.34 33.96 105.59
Days Inventory Outstanding (DIO)
162.12 86.86 81.30 73.41 58.68 75.64 45.25 40.48 35.81 49.13 51.09
Days Payable Outstanding (DPO)
174.28 109.72 98.46 79.98 66.12 87.28 56.63 55.42 44.02 59.70 73.49
Cash Conversion Cycle (CCC)
41.36 106.66 13.55 20.20 9.19 148.71 79.78 16.09 16.13 23.39 83.20
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
58 160 104 237 238 333 359 307 305 315 299
Invested Capital Turnover
4.71 2.18 3.81 1.62 1.24 0.50 0.96 0.91 1.05 0.88 0.65
Increase / (Decrease) in Invested Capital
96 206 133 263 180 173 255 70 67 -18 -60
Enterprise Value (EV)
-70 -16 68 177 165 241 126 113 81 132 235
Market Capitalization
365 392 532 501 468 423 307 344 313 361 464
Book Value per Share
$4.93 $5.69 $5.69 $5.61 $5.38 $5.29 $5.62 $5.60 $5.57 $5.63 $5.48
Tangible Book Value per Share
$4.58 $5.26 $5.30 $5.16 $4.98 $4.42 $4.65 $4.69 $4.73 $4.87 $4.74
Total Capital
504 600 603 679 649 667 686 682 671 676 658
Total Debt
0.00 11 13 82 70 114 108 104 94 92 91
Total Long-Term Debt
0.00 11 13 82 70 114 106 102 94 92 91
Net Debt
-446 -429 -485 -360 -341 -220 -218 -271 -272 -269 -268
Capital Expenditures (CapEx)
0.02 0.04 0.27 143 2.23 3.29 2.09 2.21 6.06 6.33 7.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)
17 87 29 7.82 19 39 65 21 24 40 22
Debt-free Net Working Capital (DFNWC)
463 527 527 450 430 373 392 396 390 401 381
Net Working Capital (NWC)
463 527 527 450 430 373 389 394 390 401 381
Net Nonoperating Expense (NNE)
-17 -18 -1.27 5.50 4.47 2.96 6.91 -7.23 -2.10 -15 12
Net Nonoperating Obligations (NNO)
-446 -429 -485 -360 -341 -220 -218 -271 -272 -269 -268
Total Depreciation and Amortization (D&A)
3.36 4.58 4.57 7.41 9.76 12 11 11 11 10 8.49
Debt-free, Cash-free Net Working Capital to Revenue
38.58% 69.52% 20.21% 4.58% 10.32% 32.00% 29.12% 8.48% 8.41% 14.03% 10.36%
Debt-free Net Working Capital to Revenue
1,049.63% 421.16% 369.10% 263.42% 235.56% 304.88% 176.04% 159.78% 137.20% 140.61% 177.05%
Net Working Capital to Revenue
1,049.63% 421.16% 369.10% 263.42% 235.56% 304.88% 174.96% 158.81% 137.20% 140.61% 177.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.02) $0.99 $0.00 ($0.08) ($0.14) ($0.14) $0.25 ($0.03) ($0.03) $0.04 ($0.16)
Adjusted Weighted Average Basic Shares Outstanding
94.33M 75.30M 99.75M 100.08M 99.85M 99.21M 96.02M 96.24M 96.45M 96.29M 96.49M
Adjusted Diluted Earnings per Share
($0.03) $1.04 $0.00 ($0.08) ($0.14) ($0.14) $0.25 ($0.03) ($0.03) $0.03 ($0.16)
Adjusted Weighted Average Diluted Shares Outstanding
99.89M 99.90M 99.75M 100.38M 97.37M 96.09M 96.17M 96.44M 96.46M 96.48M 96.59M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
99.89M 99.90M 100.02M 100.38M 97.37M 96.09M 96.17M 96.44M 96.46M 96.48M 96.59M
Normalized Net Operating Profit after Tax (NOPAT)
-9.21 39 -1.46 -3.33 -7.19 -11 30 -8.67 -4.50 -10 -5.85
Normalized NOPAT Margin
-79.31% 38.88% -6.01% -12.89% -30.85% -22.66% 24.46% -16.92% -7.57% -20.93% -10.79%
Pre Tax Income Margin
22.09% 72.83% -5.34% -61.50% -26.43% -30.30% 23.80% -1.74% -5.66% 11.88% -37.18%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.00 479.08 0.00 0.00 0.00 3.18 12.06 -0.64 -1.85 1.32 -11.18
NOPAT to Interest Expense
-108.95 432.92 0.00 0.00 0.00 -1.72 12.42 -3.72 -2.02 -5.30 -3.10
EBIT Less CapEx to Interest Expense
8.88 478.80 0.00 0.00 0.00 2.67 11.20 -1.59 -4.57 -1.88 -15.22
NOPAT Less CapEx to Interest Expense
-109.06 432.64 0.00 0.00 0.00 -2.23 11.57 -4.67 -4.73 -8.50 -7.14
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-8.35% 2.03% 1.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-8.35% 2.03% 1.18% 0.00% 13.32% -58.47% 0.00% 0.00% 228.85% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Acacia Research (NASDAQ: ACTG) shows a mixed but financially resilient picture in Q1 2026. The company generated modest operating cash flow despite a quarterly net loss, and it still ended the quarter with a very large cash and investment position. However, profitability has weakened sharply from the stronger results seen in 2024, and debt remains meaningful.

  • Cash and short-term investments remained strong at roughly $358.5 million in Q1 2026, giving the company a sizable liquidity cushion.
  • Operating cash flow was positive at $3.4 million, showing the business still produced cash from core operations despite reporting a loss.
  • The company also generated a large amount of non-operating cash through investment sales, helping support liquidity.
  • Quarter-end total equity and noncontrolling interests were $567.2 million, which is a sizable capital base relative to liabilities.
  • Revenue in Q1 2026 was $54.2 million, up from $50.1 million in Q4 2025 and $51.2 million in Q2 2025, suggesting top-line stability.
  • Gross profit margin was about 22% in Q1 2026, below the much stronger margin profile the company posted in parts of 2024.
  • Total assets of $755.9 million were broadly stable versus prior quarters, but the asset mix includes a meaningful amount of goodwill and intangibles.
  • The company posted a net loss of $17.6 million in Q1 2026, a sharp deterioration from the $4.8 million profit in Q4 2025.
  • Operating income was negative at $8.4 million, indicating core operations were not profitable in the quarter.
  • Long-term debt stood at $90.5 million, so leverage is still a factor investors need to watch.

Longer-term trend: Acacia’s results have been volatile over the last four years. The company produced very strong earnings in parts of 2023 and early 2024, but performance weakened materially in 2025 and Q1 2026. The balance sheet still looks liquid, but profitability has clearly cooled.

Bottom line: ACTG appears to have enough cash and investment liquidity to stay flexible, but investors should focus on whether management can restore consistent operating profitability and reduce reliance on one-time gains or investment-related income.

07/05/26 02:45 PM ETAI Generated. May Contain Errors.

Acacia Research Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Acacia Research's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Acacia Research's net income appears to be on a downward trend, with a most recent value of $24.47 million in 2025, falling from -$157.48 million in 2015. The previous period was -$34.70 million in 2024. See Acacia Research's forecast for analyst expectations on what's next for the company.

Acacia Research's total operating income in 2025 was $6.41 million, based on the following breakdown:
  • Total Gross Profit: $84.48 million
  • Total Operating Expenses: $78.07 million

Over the last 10 years, Acacia Research's total revenue changed from $125.04 million in 2015 to $285.23 million in 2025, a change of 128.1%.

Acacia Research's total liabilities were at $186.92 million at the end of 2025, a 8.3% decrease from 2024, and a 453.9% increase since 2015.

In the past 10 years, Acacia Research's cash and equivalents has ranged from $57.36 million in 2019 to $340.09 million in 2023, and is currently $306.72 million as of their latest financial filing in 2025.

Over the last 10 years, Acacia Research's book value per share changed from 6.11 in 2015 to 5.63 in 2025, a change of -7.9%.



Financial statements for NASDAQ:ACTG last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners